Sisätautien vastuualue

Julkaisut 2011
Publications 2011

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Ala-Houhala I, Saha H. Dialyysihoitoa ei pidä aloittaa liian aikaisin.
2 Alanen H-M et al. Psyykenlääkkeiden aiheuttama hyponatremia tavallista ikääntyneillä.
3 Alanko J et al. Ensitietoryhmä on hyvä aloitus typpi 1 diabeetikoiden omahoito.
4 Clement J et al. Severe crescentic glomerulonephritis linked to an acute Hantaan virus Infection?
5 Huttunen N-P et al. Systematic literature review of symptoms, signs and severity of serologically confirmed nephropathia epidemica in paediatric and adult patients.
6 Huttunen R, Aittoniemi J. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis.
7 Huttunen R et al. Smoking and the outcome of infection.
8 Huttunen R et al. High Plasma Level of Long Pentraxin 3 (PTX3) Is Associated with Fatal Disease in Bacteremic Patients: A Prospective Cohort Study.
9 Huttunen R et al. Fatal Outcome in Bacteremia is Characterized by High Plasma Cell Free DNA Concentration and Apoptotic DNA Fragmentation: A Prospective Cohort Study.
10 Huttunen R et al. Käsikoruista on vaikea luopua.
11 Huttunen R et al. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study.
12 Ilanne-Parikka P. Metabolic syndrome.
13 Jin HT et al. Association between remote organ injury and tissue polyamine homeostasis in acute experimental pancreatitis - treatment with a polyamine analogue bismethylspermine.
14 Kreutzman A et al. Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-a Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile.
15 Kujala UM et al. Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study among individuals at high risk for type 2 diabetes.
16 Laine J et al. An extensive gastroenteritis outbreak after drinking-water contamination by sewage effluent, Finland.
17 Laine O et al. Platelet ligands and ADAMTS13 during Puumala hantavirus infection and associated thrombocytopenia.
18 Pietiläinen K et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation.
19 Lindström J et al. Eurooppalainen suositus diabeteksen ehkäisystä.
20 Luoto R et al. Primary Prevention of Gestational Diabetes Mellitus and Large-for-Gestational-Age Newborns by Lifestyle Counseling: A Cluster-Randomized Controlled Trial.
21 Metso S. Glykosyloitunut hemoglobiini diabeteksen diagnostiikassa.
22 Metso S. Miten tunnistan ja hoidan diabeetikon perifeerisen neuropatian?
23 Metso S et al. Feokromosytooma ja raskaus.
24 Metso S et al. Uusia tuulia tyypin 1 diabeetikon hoidon aloitukseen.
25 Miettinen M. Outcome of Puumala Hantavirus-induced Nephropathia Epidemica.
26 Miettinen M et al. Glomerulonephritis emerging shortly after Puumala hantavirus infection: a report on 7 patients.
27 Mustila A et al. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
28 Mäkelä S et al. Steady state pharmacokinetics and dose equivalents of oral clodronate in renal failure.
29 Neva MH et al. Chronic back pain in patients with rheumatoid arthritis and in a control population: prevalence and disability--a 5-year follow-up.
30 Outinen TK et al. High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica.
31 Pajunen P et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey.
32 Pakarinen TK et al. The Effect of Zoledronic Acid on the Clinical Resolution of Charcot Neuroarthropathy: A pilot randomized controlled trial.
33 Pertovaara M et al. Novel carbonic anhydrase autoantibodies and renal manifestations in patients with primary Sjogren's syndrome.
34 Pertovaara M, Korpela M. Serum ß2 microglobulin correlates with the new ESSDAI in patients with Sjogren's syndrome.
35 Pertovaara M, Korpela M. Serum ß 2 microglobulin correlates with the new ESSDAI in patients with Sjögren's syndrome.
36 Rahikka P et al. Meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia in Tampere University Hospital: a case-control study, Finland October 2002 to January 2010.
37 Rantalaiho V et al. Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007.
38 Rautio N et al. Socioeconomic position and effectiveness of lifestyle intervention in prevention of type 2 diabetes: One-year follow-up of the FIN-D2D project.
39 Salopuro T et al. Population-level effects of the national diabetes effects of the national diabetes prevention programme (FIN-D2D) on the body wight, the waist circumference, and the prevalence of obesity.
40 Saltevo J et al. Serum Calcium level is associated with metabolic syndrome in the general population: FIN:2D2 study .
41 Saltevo JT et al. Ageing and associations of fasting plasma glucose and 2h plasma glucose with HbA(1C) in apparently healthy population. "FIN-D2D" study.
42 Seppälä E et al. Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media.
43 Simonsson B et al. Combination of pegylated IFN-{alpha}2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
44 Sinisalo M et al. Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.
45 Skyttä ET et al. Early results of 827 trabecular metal revision shells in acetabular revision.
46 Skyttä ET et al. Increasing incidence of hip arthroplasty for primary osteoarthritis in 30- to 59-year-old patients.
47 Sokka T et al. Remission: A realistic goal in rheumatoid arthritis?
48 Tahvanainen A. Whole Body ImpedanceCardioraphy and Continuous Pulse Wave Analysis in the Measurement of Human Haemodynamics during Passive Head-up Tilt.
49 Tahvanainen A et al. Reduced systemic vascular resistance in healthy volunteers with presyncopal symptoms during nitrate-stimulated tilt-table test.
50 Tulokas S et al. Verensokerin omaseuranta raskausdiabeteksessa vähentää sikiön makrosomian riskiä.
51 Uotila T et al. Reactive arthritis in a population exposed to an extensive waterborne gastroenteritis outbreak after sewage contamination in Pirkanmaa, Finland.
52 Valve K et al. Tuberkuloosiepidemian selvittäminen.
53 Virkki L et al. Outcomes of switching anti-TNF drugs in rheumatoid arthritis - a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN).
54 Wikström K et al. Socio-economic differences in dysglycemia and lifestyle-related risk factors in the Finnish middle-aged population.
55 Wirta O. Munuaisten akuutti vajaatoiminta.

Julkaisutietokanta 21.9.2012 Publications Data Base 21.9.2012